Scotts Miracle-Gro Co (SMG) stock
Close on Nov 17, 2026Market cap $3.64BP/E 51.7Yield 4.22%
Earnings
Scotts Miracle-Gro's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Scotts Miracle-Gro's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q1 FY2027ended Dec 27, 2026 | Jan 27, 2027Expected | – | – | – | – | – |
| Q4 FY2026ended Sep 30, 2026 | Nov 4, 2026before the open | $302.90M | -21.8% | -$2.10 | -$2.16 | Release |
| Q3 FY2026ended Jun 27, 2026 | Jul 29, 2026before the open | $1.17B | -1.7% | $1.75 | $2.82 | Release |
| Q2 FY2026ended Mar 28, 2026 | Apr 29, 2026before the open | $1.46B | +2.8% | $4.46 | $4.53 | Release |
| Q1 FY2026ended Dec 27, 2025 | Jan 28, 2026before the open | $354.40M | -15.0% | -$2.16 | -$0.77 | Release |
| Q4 FY2025ended Sep 30, 2025 | Nov 5, 2025before the open | $387.40M | -6.6% | -$2.63 | -$1.96 | Release |
| Q3 FY2025ended Jun 28, 2025 | Jul 30, 2025before the open | $1.19B | -0.8% | $2.54 | $2.59 | Release |
| Q2 FY2025ended Mar 29, 2025 | Apr 30, 2025before the open | $1.42B | -7.2% | $3.72 | $3.98 | Release |
| Q1 FY2025ended Dec 28, 2024 | Jan 29, 2025before the open | $416.80M | +1.6% | -$1.21 | -$0.89 | Release |
| Q4 FY2024ended Sep 30, 2024 | Nov 6, 2024before the open | $414.70M | +10.7% | -$4.29 | -$2.31 | Release |
| Q3 FY2024ended Jun 29, 2024 | Jul 31, 2024before the open | $1.20B | +7.1% | $2.28 | $2.31 | Release |
| Q2 FY2024ended Mar 30, 2024 | May 1, 2024before the open | $1.53B | 0.0% | $2.74 | $3.69 | Release |
| Q1 FY2024ended Dec 30, 2023 | Feb 7, 2024before the open | $410.40M | -22.1% | -$1.42 | -$1.45 | Release |
| Q4 FY2023ended Sep 30, 2023 | Nov 1, 2023before the open | $374.50M | -24.1% | -$8.33 | -$2.77 | Release |
| Q3 FY2023ended Jul 1, 2023 | Aug 2, 2023before the open | $1.12B | -5.9% | $0.77 | $1.17 | Release |
| Q2 FY2023ended Apr 1, 2023 | May 3, 2023before the open | $1.53B | -8.9% | $1.94 | $3.78 | Release |
| Q1 FY2023ended Dec 31, 2022 | Feb 1, 2023before the open | $526.60M | -7.0% | -$1.17 | -$1.02 | Release |
| Q4 FY2022ended Sep 30, 2022 | Nov 2, 2022before the open | $493.60M | -33.1% | -$3.97 | -$2.04 | Release |
| Q3 FY2022ended Jul 2, 2022 | Aug 3, 2022before the open | $1.19B | – | -$8.01 | $1.98 | Release |
| Q2 FY2022ended Apr 2, 2022 | May 3, 2022before the open | $1.68B | – | $4.94 | $5.03 | Release |
| Q1 FY2022ended Jan 1, 2022 | Feb 1, 2022before the open | $566.00M | – | -$0.90 | -$0.88 | Release |
| Q4 FY2021ended Sep 30, 2021 | Nov 3, 2021before the open | $737.80M | – | -$0.87 | -$0.82 | Release |
| Q3 FY2021ended Jul 3, 2021 | Aug 4, 2021before the open | – | – | – | – | Filing |
| Q2 FY2021ended Apr 3, 2021 | May 5, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Jan 2, 2021 | Jan 11, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Sep 30, 2020 | Nov 4, 2020before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Scotts Miracle-Gro's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales growth | FY2027 | +2% – +4% | – | New | Nov 4, 2026 |
| EBITDA | FY2027 | $700.00M | – | New | Jan 29, 2025 |
| Non-GAAP adjusted earnings per share from continuing operationsnon-GAAP | FY2027 | $4.70 – $4.90 | – | New | Nov 4, 2026 |
| Free cash flownon-GAAP | FY2027 | $275.00M | – | New | Nov 4, 2026 |
Guidance vs results
The last range Scotts Miracle-Gro gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | non-GAAP adjusted diluted net income per share from continuing operations | $4.30 – $4.45 | $4.42Σ4Q | Within range |
| FY2025 | Non-GAAP adjusted earnings per share | $3.50 | $3.72Σ4Q | Above range |
Guidance history
Every forecast Scotts Miracle-Gro put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 4, 2026 | Non-GAAP adjusted earnings per share from continuing operations | FY2027 | $4.70 – $4.90 | New |
| Nov 4, 2026 | Free cash flow | FY2027 | $275.00M | New |
| Nov 4, 2026 | Net sales growth | FY2027 | +2% – +4% | New |
| Jul 29, 2026 | non-GAAP adjusted diluted net income per share from continuing operations | FY2026 | $4.30 – $4.45 | Raised |
| Jul 29, 2026 | Free cash flow | FY2026 | $275.00M | Reaffirmed |
| Jul 29, 2026 | Non-GAAP adjusted gross margin rate | FY2026 | 32% | Reaffirmed |
| Jul 29, 2026 | full year tax rate | FY2026 | 27% – 28% | New |
| Apr 29, 2026 | Non-GAAP adjusted net income per share from continuing operations | FY2026 | $4.15 – $4.35 | Reaffirmed |
| Apr 29, 2026 | Free cash flow | FY2026 | $275.00M | New |
| Apr 29, 2026 | Non-GAAP adjusted gross margin rate | FY2026 | 32% | Reaffirmed |
| Jan 28, 2026 | Non-GAAP adjusted net income per share from continuing operations | FY2026 | $4.15 – $4.35 | Reaffirmed |
| Jan 28, 2026 | Free cash flow | FY2026 | $275.00M | Reaffirmed |
| Jan 28, 2026 | Non-GAAP adjusted gross margin | FY2026 | 32% | Reaffirmed |
| Nov 5, 2025 | Non-GAAP adjusted earnings per share | FY2026 | $4.15 – $4.35 | New |
| Nov 5, 2025 | Free cash flow | FY2026 | $275.00M | New |
| Nov 5, 2025 | Non-GAAP adjusted gross margin | FY2026 | 32% | New |
| Jul 30, 2025 | Non-GAAP adjusted EBITDA | FY2025 | $570.00M – $590.00M | New |
| Jul 30, 2025 | Non-GAAP adjusted earnings per share | FY2025 | $3.50 | New |
| Jul 30, 2025 | Free cash flow | FY2025 | $250.00M | New |
| Jul 30, 2025 | Non-GAAP adjusted gross margin | FY2025 | 30% | New |
| Jan 29, 2025 | Non-GAAP adjusted EBITDA | FY2025 | $570.00M – $590.00M | New |
| Jan 29, 2025 | EBITDA | FY2027 | $700.00M | New |
| Jan 29, 2025 | Non-GAAP adjusted gross margin | FY2025 | 30% | New |
| Jan 29, 2025 | Interest expense | FY2025 | $15.00M – $20.00M | Lowered |
| Nov 6, 2024 | incremental investments in our brands | FY2025 | $40.00M | New |
| Jul 31, 2024 | Hawthorne net sales | FY2024 | -40% – -35% | New |
| May 1, 2024 | adjusted EBITDA | FY2024 | $575.00M | Reaffirmed |
| May 1, 2024 | free cash flow | FY2024 | $560.00M | Reaffirmed |
| Feb 7, 2024 | adjusted EBITDA | FY2024 | $575.00M | New |
| Feb 7, 2024 | free cash flow | FY2024 | $560.00M | New |
| Feb 7, 2024 | Non-GAAP Adjusted Gross Margin Improvement | FY2024 | 250 | New |
| Aug 2, 2023 | Adjusted EBITDA | FY2023 | +25% | New |
| Aug 2, 2023 | operating income | FY2023 | 7% – 7.5% | New |
| Aug 2, 2023 | tax rate | FY2023 | 28% – 29% | Raised |
| Aug 2, 2023 | SG&A | FY2023 | 15% – 16% | Lowered |
| Aug 2, 2023 | total net sales | FY2023 | +10% – +11% | Raised |
| May 3, 2023 | Free cash flow | FY2023 | $1.00B | New |
| May 3, 2023 | Effective tax rate | FY2023 | 27% – 28% | Raised |
| May 3, 2023 | Interest expense increase | FY2023 | $60.00M | Reaffirmed |
| Feb 1, 2023 | Free cash flow | over the next two years | $1.00B | – |
| Feb 1, 2023 | Effective tax rate | FY2023 | 26% – 27% | Raised |
| Feb 1, 2023 | Interest expense increase | FY2023 | $60.00M | Raised |
| Feb 1, 2023 | Hawthorne segment net sales | FY2023 | -30% – -20% | New |
| Nov 2, 2022 | Free cash flow | next two years | $1.00B | – |
| Nov 2, 2022 | Effective tax rate | FY2023 | 25% – 26% | New |
| Nov 2, 2022 | Interest expense increase | FY2023 | $35.00M – $40.00M | New |
| Aug 3, 2022 | adjusted EPS | FY2022 | $4.00 – $4.20 | Lowered |
| Aug 3, 2022 | SG&A | FY2022 | -15% | New |
| Aug 3, 2022 | sales | FY2022 | -9% – -8% | Lowered |
| Feb 1, 2022 | sales | FY2022 | -2% – +2% | Lowered |
| Nov 3, 2021 | Non-GAAP adjusted earnings per share | FY2022 | $8.50 – $8.90 | New |
| Nov 3, 2021 | sales growth | FY2022 | 0% – +3% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Scotts Miracle-Gro filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?